AeroLeads people directory · profile

Robert A. Herrmann Email & Phone Number

Director of Neurointerventional Regulatory Affairs at MCRA
Location: Washington, District of Columbia, United States 9 work roles 2 schools
1 work email found @mcra.com 2 phones found area 410 LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 2 phones

Work email r****@mcra.com
Direct phone (410) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Director of Neurointerventional Regulatory Affairs
Location
Washington, District of Columbia, United States

Who is Robert A. Herrmann? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Robert A. Herrmann is listed as Director of Neurointerventional Regulatory Affairs at MCRA, based in Washington, District of Columbia, United States. AeroLeads shows a work email signal at mcra.com, phone signal with area code 410, and a matched LinkedIn profile for Robert A. Herrmann.

Robert A. Herrmann previously worked as Team Lead Neurointerventional Devices at Fda Cdrh and Lead Reviewer Neurointerventional Devices at Fda Cdrh. Robert A. Herrmann holds Phd, Biomedical Engineering from Duke University.

Company email context

Email format at MCRA

This section adds company-level context without repeating Robert A. Herrmann's masked contact details.

{first_initial}{last}@mcra.com
86% confidence

AeroLeads found 1 current-domain work email signal for Robert A. Herrmann. Compare company email patterns before reaching out.

Profile bio

About Robert A. Herrmann

In my current position, I am leveraging 20+ years of experience in the medical device field to advance care for patients and assist companies to bring their devices to market.I am detail oriented, have great innovation skills, and a breath of knowledge covering medical devices, biomaterials, physiology, vascular biology, interventional cardiology and wound closure. I have 6 years FDA experience in the neurointerventional device area covering, PMAs, 510(k)s, IDEs, combination products and post-market issues. Strong background in medical device product development and the quality systems used during the product life cycle. I am an encouraging, successful and adventurous collaborator, creating positive team results and lasting relationships with team members, collaborators and CRO’s. Strong communication skills. Proficient in writing and presentation skills for both scientific, business and lay audiences. Prolific innovator with numerous issued patents and published applications.Specialties: Medical Device Regulatory Affairs, Project management, Team Management, Medical Devices, Product innovation, Preclinical Research, Budgeting, Vascular Biology, Wound Healing

Listed skills include Program Management, Budget Management, Engineering Management, Medical Devices, and 30 others.

Current workplace

Robert A. Herrmann's current company

Company context helps verify the profile and gives searchers a useful next step.

MCRA
Mcra
Director of Neurointerventional Regulatory Affairs
AeroLeads page
9 roles · 39 years

Robert A. Herrmann work experience

A career timeline built from the work history available for this profile.

Director Of Neurointerventional Regulatory Affairs

Current

Washington, Dc, Us

Aug 2021 - Present

Team Lead Neurointerventional Devices

Fda Cdrh
Jun 2016 - Aug 2021

Lead Reviewer Neurointerventional Devices

Fda Cdrh
Feb 2015 - Jun 2016

Vice President Engineering

Evasc Medical Systems
Oct 2008 - Jan 2015

Engineering Manager

Westwood, Massachusetts, Us

- Project Manager for the development of two 510K submissions for the Quill barbed suture product.- Led team in the development of improved manufacturing machines,novel product test methods and improved product quality.- Served as chairman of Angiotech’s Animal Care Committee. - Reviewed and approved animal use protocols, developed and modified animal care SOPs.- Inventor on numerous (>10) patent applications.

Nov 2006 - Aug 2008

Principal Scientist, Sr. Research Scientist, Research Scientist

Marlborough, Ma, Us

- Team Leader for technology evaluation in the area of drug eluting stents. - Led internal efforts to develop novel drug eluting stent coating in collaboration with small pharmaceutical company and academic scientists. - Mentor and supervise biologist and pharmaceutical scientist.- Led external team in pre-clinical research on drug eluting stent mechanism of action, resulting in three publications.- Initiated corporate program for development of new Pre-Clinical methods and models for drug eluting stent development.- Supported due diligence efforts on biomaterials and pharmaceutical/biotech technologies.- Inventor on six issued patents and numerous patent applications.- Successfully initiated in vitro cell culture assays both internally and externally in support of technology development programs. - Led bi-annual company-wide forum on drug-device combination technology evaluation within Boston Scientific.

Jan 2000 - Nov 2006

Post-Doctoral Researcher

Chapel Hill, Nc, Us

- Researched the role of von Willebrand factor in stented atherosclerotic vessels using in situ hybridization and immunohistological techniques.- Assisted in pre-clinical experiments using a porcine infarct model.- Developed antisense RNA marker for von Willebrand factor using molecular biology techniques.- Assisted in pre-clinical experiments using proteosome inhibition of NF-KB to reduce tissue damage in a myocardial infarct model.

Sep 1998 - Dec 1999

Post-Doc / Consultant

Department Of Cardiology, Klinikum Rechts Der Isar, Munich, Germany

- Establish laboratory for histological and immunohistological evaluation of stented coronary arteries. - Lead research project to develop an anti-restenosis radioactive coronary stent.- Set up laboratory and developed protocols for histological and immunohistological evaluation of stented coronary arteries.- Completed evaluation of radioactive stents in a porcine model.Assisted in manufacture, testing and evaluation of a drug-eluting, polymer coated coronary stent.

Sep 1996 - Sep 1998

Project Engineer

Canon Virginia

- Led engineering team in start-up of new toner production line.- Brought several domestic raw materials on-line, ensuring product quality.- Provided technical support for toner manufacturing and quality assurance.

1988 - 1990 ~2 yrs
2 education records

Robert A. Herrmann education

Phd, Biomedical Engineering

Duke University

Bs, Chemical Engineering

University Of Virginia
FAQ

Frequently asked questions about Robert A. Herrmann

Quick answers generated from the profile data available on this page.

What company does Robert A. Herrmann work for?

Robert A. Herrmann works for MCRA.

What is Robert A. Herrmann's role at MCRA?

Robert A. Herrmann is listed as Director of Neurointerventional Regulatory Affairs at MCRA.

What is Robert A. Herrmann's email address?

AeroLeads has found 1 work email signal at @mcra.com for Robert A. Herrmann at MCRA.

What is Robert A. Herrmann's phone number?

AeroLeads has found 2 phone signal(s) with area code 410 for Robert A. Herrmann at MCRA.

Where is Robert A. Herrmann based?

Robert A. Herrmann is based in Washington, District of Columbia, United States while working with MCRA.

What companies has Robert A. Herrmann worked for?

Robert A. Herrmann has worked for Mcra, Fda Cdrh, Evasc Medical Systems, Angiotech Pharmaceuticals, and Boston Scientific.

How can I contact Robert A. Herrmann?

You can use AeroLeads to view verified contact signals for Robert A. Herrmann at MCRA, including work email, phone, and LinkedIn data when available.

What schools did Robert A. Herrmann attend?

Robert A. Herrmann holds Phd, Biomedical Engineering from Duke University.

What skills is Robert A. Herrmann known for?

Robert A. Herrmann is listed with skills including Program Management, Budget Management, Engineering Management, Medical Devices, Project Management, Product Innovation, Team Management, and Fda.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.